Recent Security Class Actions

SeaStar Medical Holding Corporation Common Stock (NASDAQ: ICU)

49 Days left to seek lead plaintiff status.

Company Name:SeaStar Medical Holding Corporation Common Stock
Stock Symbol:NASDAQ: ICU
Class Period Start:10/31/2022
Class Period End (inclusive):03/26/2024
Filing Deadline:09/03/2024

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) SeaStar and/or Legacy SeaStar had deficient compliance controls and procedures related to the HDE Application to the FDA for use of Selective Cytopheretic Device ("SCD"); (ii) accordingly, there were deficiencies with the HDE Application, the FDA was unlikely to approve the HDE Application in its present form, and the SCD’s regulatory prospects were overstated; (iii) the Company had downplayed the true scope and severity of deficiencies in its financial controls and procedures, while overstating Defendants’ efforts to remediate the same; (iv) accordingly, SeaStar had failed to properly account for the classification of certain outstanding warrants and the Prepaid Forward Agreement; (v) as a result, SeaStar was likely to restate one or more of its previously issued financial statements; (vi) accordingly, SeaStar’s post-Merger business and financial prospects were overstated; and (vii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

SeaStar Medical Holding Corporation Common Stock (NASDAQ: ICU) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.